Cargando…
Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a pandemic and has caused damage to the lives of the people and economy of countries. However, the therapeutic reagents against SARS-CoV-2 remain unclear. The spike (S) p...
Autores principales: | Tanikawa, Takashi, Hayashi, Tsuyoshi, Suzuki, Ryuichiro, Kitamura, Masashi, Inoue, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444047/ https://www.ncbi.nlm.nih.gov/pubmed/34545325 http://dx.doi.org/10.1016/j.jtcme.2021.09.005 |
Ejemplares similares
-
Screening for inhibitory effects of crude drugs on furin-like enzymatic activities
por: Kiba, Yuka, et al.
Publicado: (2021) -
Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
por: Tanikawa, Takashi, et al.
Publicado: (2022) -
SARS-CoV-2 furin cleavage site was not engineered
por: Garry, Robert F.
Publicado: (2022) -
Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis
por: Johnson, Bryan A., et al.
Publicado: (2020) -
The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2
por: Chan, Yujia Alina, et al.
Publicado: (2021)